Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $178.19 million. The enterprise value is $156.47 million.
Important Dates
The next estimated earnings date is Thursday, March 13, 2025, before market open.
| Earnings Date | Mar 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 73.63 million shares outstanding. The number of shares has decreased by -0.59% in one year.
| Current Share Class | 73.63M |
| Shares Outstanding | 73.63M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | +10.79% |
| Owned by Insiders (%) | 11.35% |
| Owned by Institutions (%) | 5.55% |
| Float | 54.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.10 |
| PS Ratio | 3.88 |
| Forward PS | 9.69 |
| PB Ratio | 5.49 |
| P/TBV Ratio | 5.49 |
| P/FCF Ratio | 24.85 |
| P/OCF Ratio | 21.53 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 21.82 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.98 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.79 |
| Interest Coverage | -4.87 |
Financial Efficiency
Return on equity (ROE) is -27.18% and return on invested capital (ROIC) is -10.88%.
| Return on Equity (ROE) | -27.18% |
| Return on Assets (ROA) | -7.47% |
| Return on Invested Capital (ROIC) | -10.88% |
| Return on Capital Employed (ROCE) | -23.85% |
| Revenue Per Employee | $219,553 |
| Profits Per Employee | -$46,183 |
| Employee Count | 208 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, PLX has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.90% in the last 52 weeks. The beta is 0.75, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +66.90% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 65.31 |
| Average Volume (20 Days) | 672,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PLX had revenue of $45.67 million and -$9.61 million in losses. Loss per share was -$0.13.
| Revenue | 45.67M |
| Gross Profit | 16.38M |
| Operating Income | -8.91M |
| Pretax Income | 6.77M |
| Net Income | -9.61M |
| EBITDA | -7.62M |
| EBIT | -8.91M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $27.41 million in cash and $5.68 million in debt, giving a net cash position of $21.73 million or $0.30 per share.
| Cash & Cash Equivalents | 27.41M |
| Total Debt | 5.68M |
| Net Cash | 21.73M |
| Net Cash Per Share | $0.30 |
| Equity (Book Value) | 32.44M |
| Book Value Per Share | 0.44 |
| Working Capital | 23.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $8.28 million and capital expenditures -$1.11 million, giving a free cash flow of $7.17 million.
| Operating Cash Flow | 8.28M |
| Capital Expenditures | -1.11M |
| Free Cash Flow | 7.17M |
| FCF Per Share | $0.10 |
Full Cash Flow StatementMargins
Gross margin is 35.86%, with operating and profit margins of -19.50% and -21.03%.
| Gross Margin | 35.86% |
| Operating Margin | -19.50% |
| Pretax Margin | -21.00% |
| Profit Margin | -21.03% |
| EBITDA Margin | -16.69% |
| EBIT Margin | -19.50% |
| FCF Margin | 15.70% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.59% |
| Shareholder Yield | 0.59% |
| Earnings Yield | -5.39% |
| FCF Yield | 4.02% |
Analyst Forecast
The average price target for PLX is $15.00, which is 519.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 519.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
PLX has an Altman Z-Score of -6.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.05 |
| Piotroski F-Score | 3 |